It remains unclear whether the transcriptional targets of D-cyclins/Rb/E2F pathway are limited to regulators of the cell cycle or if they also have activities on other pathways in PDAC, including apoptosis, invasion and sensitivity to anti-cancer agents. The gene discussed is RB1; the disease is cancer.